All Stories

  1. Improving quality care for diabetes in the community: What do Cypriot patients want?
  2. Using IMPrESS to guide policy change in multiple sclerosis
  3. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients
  4. What, who and when? Incorporating a discrete choice experiment into an economic evaluation
  5. Decision-making criteria among European patients: exploring patient preferences for primary care services
  6. Patients' valuation of the prescribing nurse in primary care: a discrete choice experiment
  7. Do cancer-specific websites meet patient's information needs?
  8. The Authors’ Reply to Koeser and McCrone: “On the Use and Interpretation of Quantile Regression in Quality-of-Life Research”
  9. Survey of patients' experiences and perceptions of care provided by nurse and pharmacist independent prescribers in primary care
  10. Valuing Benefits to Inform a Clinical Trial in Pharmacy
  11. What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial
  12. Valuing the Extended Role of Prescribing Pharmacist in General Practice: Results from a Discrete Choice Experiment
  13. Development, validation and application of a patient satisfaction scale for a community pharmacy medicines-management service
  14. Diagnosis and management of idiopathic childhood constipation: summary of NICE guidance
  15. Session 1A: Methods
  16. Patients' preferences for an increased pharmacist role in the management of drug therapy
  17. Patients' preferences for an increased pharmacist role in the management of drug therapy
  18. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses
  19. Community pharmacy harm reduction services for drug misusers: national service delivery and professional attitude development over a decade in Scotland
  20. Patient Evaluation of a Community Pharmacy Medications Management Service
  21. Costs of a Community Pharmacist-Led Medicines Management Service for Patients with Coronary Heart Disease in England